VEGF vascularization pathway in human intervertebral disc does not change during the disc degeneration process

被引:12
作者
Capossela S. [1 ]
Bertolo A. [1 ]
Gunasekera K. [1 ]
Pötzel T. [2 ]
Baur M. [2 ,3 ]
Stoyanov J.V. [1 ]
机构
[1] Biomedical Laboratories, Swiss Paraplegic Research, Nottwil
[2] Swiss Paraplegic Centre, Nottwil
[3] Cantonal Hospital of Lucerne, Lucerne
关键词
FLT1; Intervertebral disc; Vascularization; VEGFR1;
D O I
10.1186/s13104-018-3441-3
中图分类号
学科分类号
摘要
Objective: During degeneration of the intervertebral disc ingrowth of blood vessels and nerves into the disc are associated with back pain. Vascular endothelial growth factors promote vasculogenesis by binding to the membrane vascular endothelial growth factor receptor 1, while shorter soluble forms of this receptor can inhibit vascularization. We hypothesized that membrane and soluble receptor forms might change between stages of intervertebral disc degeneration. Results: Expression of soluble and membrane forms of vascular endothelial growth factor receptor 1 in human degenerated intervertebral discs and healthy bovine caudal discs was assessed by qRT-PCR and immunoblot. Comparative microarray meta-analysis across disc degeneration grades showed that membrane and soluble forms of this receptor, together with other components of classic vascularization pathways, are constitutively expressed across human disc degeneration stages. Contrary to our hypothesis, we observed that expression of the classic vascularization pathway is stable across degeneration stages and we assume that soluble vascular endothelial growth factor receptor 1 does not contribute to prevent disc degeneration. However, we observed increased expression levels of genes involved in alternative vascularization signalling pathways in severely degenerated discs, suggesting that abnormal vascularization is part of the pathological progression of disc degeneration. © 2018 The Author(s).
引用
收藏
相关论文
共 42 条
[11]  
Shibuya M., Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1), Int J Biochem Cell Biol, 33, pp. 409-420, (2001)
[12]  
He Y., Smith S.K., Day K.A., Clark D.E., Licence D.R., Charnock-Jones D.S., Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity, Mol Endocrinol, 13, pp. 537-545, (1999)
[13]  
Ambati B.K., Nozaki M., Singh N., Takeda A., Jani P.D., Suthar T., Albuquerque R.J., Richter E., Sakurai E., Newcomb M.T., Et al., Corneal avascularity is due to soluble VEGF receptor-1, Nature, 443, pp. 993-997, (2006)
[14]  
Luo L., Uehara H., Zhang X., Das S.K., Olsen T., Holt D., Simonis J.M., Jackman K., Singh N., Miya T.R., Et al., Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1, Elife, 2, (2013)
[15]  
Cornejo M.C., Cho S.K., Giannarelli C., Iatridis J.C., Purmessur D., Soluble factors from the notochordal-rich intervertebral disc inhibit endothelial cell invasion and vessel formation in the presence and absence of pro-inflammatory cytokines, Osteoarthritis Cartilage, 23, pp. 487-496, (2015)
[16]  
Pfirrmann C.W., Metzdorf A., Zanetti M., Hodler J., Boos N., Magnetic resonance classification of lumbar intervertebral disc degeneration, Spine (Phila Pa 1976), 26, pp. 1873-1878, (2001)
[17]  
Khoury M.K., Parker I., Aswad D.W., Acquisition of chemiluminescent signals from immunoblots with a digital single-lens reflex camera, Anal Biochem, 397, pp. 129-131, (2010)
[18]  
Gruber H.E., Hoelscher G., Loeffler B., Chow Y., Ingram J.A., Halligan W., Hanley E.N., Prostaglandin E1 and misoprostol increase epidermal growth factor production in 3D-cultured human annulus cells, Spine J, 9, pp. 760-766, (2009)
[19]  
Gruber H.E., Hoelscher G.L., Ingram J.A., Hanley E.N., Genome-wide analysis of pain-, nerve- and neurotrophin-related gene expression in the degenerating human annulus, Mol Pain, 8, (2012)
[20]  
Herbert S.P., Stainier D.Y., Molecular control of endothelial cell behaviour during blood vessel morphogenesis, Nat Rev Mol Cell Biol, 12, pp. 551-564, (2011)